Tectonic Therapeutic Operating Expenses Growth & History (TECX)
Tectonic Therapeutic's operating expenses was $84.0M for fiscal 2025.
View full Tectonic Therapeutic company overviewTectonic Therapeutic annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $84.0M | $26.0M | +44.85% |
| 2024 | 2024-12-31 | $58.0M | $13.4M | +29.94% |
| 2023 | 2023-12-31 | $44.6M | −$60.8M | −57.65% |
| 2022 | 2022-12-31 | $105.4M | −$13.4M | −11.28% |
| 2021 | 2021-12-31 | $118.8M | −$1.4M | −1.15% |
| 2020 | 2020-12-31 | $120.2M | $44.4M | +58.59% |
| 2019 | 2019-12-31 | $75.8M | $29.6M | +63.94% |
| 2018 | 2018-12-31 | $46.2M | $27.9M | +151.51% |
| 2017 | 2017-12-31 | $18.4M | — | — |
Tectonic Therapeutic quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $24.2M | $1.9M | +8.45% |
| Q1 2026 | 2026-03-31 | $27.3M | $9.0M | +49.20% |
| Q4 2025 | 2025-12-31 | $21.5M | $7.5M | +53.81% |
| Q3 2025 | 2025-09-30 | $21.9M | $2.3M | +11.47% |
| Q2 2025 | 2025-06-30 | $22.3M | $10.9M | +95.53% |
| Q1 2025 | 2025-03-31 | $18.3M | $5.3M | +41.10% |
| Q4 2024 | 2024-12-31 | $14.0M | — | — |
| Q3 2024 | 2024-09-30 | $19.6M | $9.5M | +94.16% |
| Q2 2024 | 2024-06-30 | $11.4M | $790,000 | +7.43% |
| Q1 2024 | 2024-03-31 | $13.0M | −$12.3M | −48.58% |
| Q3 2023 | 2023-09-30 | $10.1M | −$12.9M | −56.00% |
| Q2 2023 | 2023-06-30 | $10.6M | −$17.1M | −61.72% |
| Q1 2023 | 2023-03-31 | $25.2M | −$4.2M | −14.27% |
| Q4 2022 | 2022-12-31 | $25.3M | −$2.7M | −9.67% |
| Q3 2022 | 2022-09-30 | $23.0M | −$9.6M | −29.54% |
| Q2 2022 | 2022-06-30 | $27.8M | −$3.6M | −11.48% |
| Q1 2022 | 2022-03-31 | $29.4M | $2.5M | +9.43% |
| Q4 2021 | 2021-12-31 | $28.0M | −$102,000 | −0.36% |
| Q3 2021 | 2021-09-30 | $32.6M | −$4.1M | −11.16% |
| Q2 2021 | 2021-06-30 | $31.4M | $2.5M | +8.73% |
| Q1 2021 | 2021-03-31 | $26.9M | $295,000 | +1.11% |
| Q4 2020 | 2020-12-31 | $28.1M | $4.6M | +19.76% |
| Q3 2020 | 2020-09-30 | $36.7M | $18.7M | +103.27% |
| Q2 2020 | 2020-06-30 | $28.9M | $12.2M | +73.71% |
| Q1 2020 | 2020-03-31 | $26.6M | $8.9M | +50.22% |
| Q4 2019 | 2019-12-31 | $23.4M | $6.8M | +40.52% |
| Q3 2019 | 2019-09-30 | $18.1M | $5.8M | +47.68% |
| Q2 2019 | 2019-06-30 | $16.6M | $7.1M | +74.00% |
| Q1 2019 | 2019-03-31 | $17.7M | $9.9M | +127.27% |
| Q4 2018 | 2018-12-31 | $16.7M | — | — |
| Q3 2018 | 2018-09-30 | $12.2M | $5.9M | +92.03% |
| Q2 2018 | 2018-06-30 | $9.5M | $7.0M | +275.57% |
| Q1 2018 | 2018-03-31 | $7.8M | — | — |
| Q3 2017 | 2017-09-30 | $6.4M | — | — |
| Q2 2017 | 2017-06-30 | $2.5M | — | — |
Tectonic Therapeutic operating expenses trends
Over the last five fiscal years, Tectonic Therapeutic's operating expenses decreased from $120.2M to $84.0M, a change of −$36.2M. The latest reported quarter, Q2 2026, shows $24.2M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tectonic Therapeutic source filings ↗